The writer of the article had verbal diarrhea, but luckily I read the whole thing, so I can give you the top-line summary:
• Long-term ADT improves outcome of escalated-dose EBRT for high risk PC
• Optimal duration of ADT is somewhere between 6 months and 18 months for high risk
• Short-term ADT (6 months) improves outcome of escalated-dose EBRT for intermediate risk PC.
• That benefit may be limited to unfavorable intermediate risk PC.
• The sequencing of ADT -before/during/after RT - may not matter all that much.
If you insist on reading it all for yourself, here's the link:
Androgen deprivation therapy and escalated dosing in radiation therapy- Allen